We have 3 of 18 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
In a KYSE510 xenograft model, oral administration of JH-1 significantly suppressed tumor growth without obvious toxicity and validate the quinazoline scaffold for epigenetic cancer therapy.
A mechanistically integrated overview of small-molecule immunotherapies is presented, key translational challenges are examined, and future directions for overcoming immune resistance in cancer are explored.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
